International meeting on cancer vaccines: how can we enhance efficacy of therapeutic vaccines?

Cancer Research
Filippo BelardelliEnrico Garaci

Abstract

The major aims of the International Meeting on Cancer Vaccines were to review the state-of-the-art research on cancer vaccines, to compare different experimental approaches of therapeutic vaccination and to discuss critical issues and perspectives. The results from recent clinical trials in patients treated with different types of cancer vaccines were presented. Reasons for the limited response and possible modalities for enhancing efficacy of therapeutic vaccines were subjects of major discussion. A consensus was achieved on the need of combining cancer vaccines with other anticancer treatments. Of note, evidence stemming from studies in animal models pointed out new rationales for a selective combination of cancer vaccines with chemotherapy. In addition, some main presentations focused on new adjuvants (CpG oligonucleotides) and on the role of cytokines (i.e., type I IFN, interleukin 12, and interleukin 15) in promoting an antitumor immune response to vaccines. A considerable attention was given to regulatory T cells and to strategies for suppressing their function, thus enhancing vaccine efficacy. An entire session was devoted to the use of dendritic cells for the development of cancer vaccines. The results of clinical studi...Continue Reading

Citations

Aug 23, 2006·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·K RassW Tilgen
Aug 11, 2006·Der Urologe. Ausg. A·A HaferkampM Hohenfellner
Aug 16, 2008·Cancer Immunology, Immunotherapy : CII·Constantin N BaxevanisMichael Papamichail
Jul 20, 2005·Anti-cancer Drugs·D J van SpronsenP H M De Mulder
May 10, 2006·Immunology and Cell Biology·Sebastien ViattePedro Romero
Jun 24, 2006·The Journal of Clinical Investigation·Hiroyoshi NishikawaSacha Gnjatic
Nov 21, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Marion Jurk, Jörg Vollmer
Feb 19, 2008·Expert Review of Anticancer Therapy·Christina S ChuGeorge Coukos
Jan 26, 2007·Expert Opinion on Biological Therapy·Dolores J Schendel
May 29, 2007·Biochimie·Maria FerrantiniFilippo Belardelli
Jun 15, 2007·Annals of the New York Academy of Sciences·Laura BracciFilippo Belardelli
Oct 8, 2008·International Journal of Cancer. Journal International Du Cancer·Paola NisticòEnrico Proietti
Dec 24, 2005·Pathology·Kristen J RadfordDerek N J Hart
Mar 11, 2005·Expert Opinion on Biological Therapy·David C Tscharke, Andreas Suhrbier
Aug 27, 2005·Expert Opinion on Biological Therapy·George CoukosT-C Wu
Jun 7, 2005·Expert Opinion on Biological Therapy·Jörg Vollmer
Jul 25, 2006·Advances in Cancer Research·Aniruddha ChoudhuryHåkan Mellstedt
May 24, 2005·European Journal of Immunology·Barbara R von BeustThomas M Kündig
Jan 19, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D SchadendorfUNKNOWN DC study group of the DeCOG
Mar 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anna CasatiAnna Mondino
May 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hiroyoshi NishikawaKunle Odunsi
Nov 1, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cristina MaccalliFilippo Belardelli
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin R WeihrauchLee M Nadler
Jun 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John G GribbenLee M Nadler
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ettore BiagiMalcolm Brenner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.